https://www.novumpr.nl/2017/09/20/ipsen-receives-approval-from-european-commission-for-xermelo-telotristat-ethyl-for-the-treatment-of-carcinoid-syndrome-diarrhea-in-patients-inadequately-controlled-by-somatostatin-analogue-the/?utm_source=rss&utm_medium=rss&utm_campaign=ipsen-receives-approval-from-european-commission-for-xermelo-telotristat-ethyl-for-the-treatment-of-carcinoid-syndrome-diarrhea-in-patients-inadequately-controlled-by-somatostatin-analogue-the NovumPR press releases Wed, 20 Sep 2017 07:42:32 +0000 hourly 1 https://wordpress.org/?v=6.8.3